Abstract
The mechanisms underlying sterol transport in mammalian cells are poorly understood. In particular, how cholesterol internalized from HDL is made available to the cell for storage or modification is unknown. Here, we describe three ER-resident proteins (Aster-A, -B, -C) that bind cholesterol and facilitate its removal from the plasma membrane. The crystal structure of the central domain of Aster-A broadly resembles the sterol-binding fold of mammalian StARD proteins, but sequence differences in the Aster pocket result in a distinct mode of ligand binding. The Aster N-terminal GRAM domain binds phosphatidylserine and mediates Aster recruitment to plasma membrane-ER contact sites in response to cholesterol accumulation in the plasma membrane. Mice lacking Aster-B are deficient in adrenal cholesterol ester storage and steroidogenesis because of an inability to transport cholesterol from SR-BI to the ER. These findings identify a nonvesicular pathway for plasma membrane to ER sterol trafficking in mammals. A nonvesicular pathway for plasma membrane to ER sterol trafficking in mammals is mediated by sterol-binding ER-resident Aster proteins.
| Original language | English |
|---|---|
| Pages (from-to) | 514-529.e20 |
| Journal | Cell |
| Volume | 175 |
| Issue number | 2 |
| DOIs | |
| State | Published - Oct 4 2018 |
Bibliographical note
Publisher Copyright:© 2018 Elsevier Inc.
Funding
We thank J. Kim, S. Munday, P. Rajbhandari, and T. Sallam for technical assistance and experimental guidance. Confocal microscopy was performed at the California NanoSystems Institute Advanced Light Microscopy/Spectroscopy Facility. We thank Diamond Light Source for beamtime (proposal MX14692) and the staff of beamlines I04-1, I03, and I24 for assistance with crystal testing and data collection. We dedicate this manuscript to the memory of Jaspal Singh Sandhu. His courageous battle with coronary artery disease has been a key inspiration to this work. J.S. was supported by NIH grants ( GM08042 and T32HL69766 ) and a P. Whitcome Fellowship. J.O. was supported by an NIH grant ( 5T34GM008563 ). This research was also supported by grants from the NIH ( HL066088 , DK100627 , S10RR019232 , and GM115553 ), the Academy of Finland ( 307415 , 312491 , and 275964 ), the Sigrid Juselius Foundation , and the Helsinki Institute of Life Science Imaging Unit and Biomedicum Functional Genomics Unit . J.W.R.S. is a Wellcome Trust Senior Investigator ( WT100237 ) and Royal Society Wolfson Research Merit Award Holder.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| Helsinki Institute of Life Science Imaging Unit | |
| Sigrid Juséliuksen Säätiö | |
| National Institute of Diabetes and Digestive and Kidney Diseases | R01DK100627 |
| National Heart, Lung, and Blood Institute (NHLBI) | R01HL136618, T32HL069766, R01HL066088 |
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | T34GM008563, T32GM008042, R01GM115553 |
| Biotechnology and Biological Sciences Research Council | BB/P003818/1, BB/M011801/1 |
| Academy of Finland | 312491, 307415 |
| Seventh Framework Programme | 275964 |
| Wellcome Trust | WT100237 |
| National Center for Research Resources | S10RR019232 |
Keywords
- HDL metabolism
- LXR
- SR-BI
- SREBP
- cholesterol
- membrane contact sites
- nonvesicular transport
- steroidogenesis
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology